5A apolipoprotein mimetic peptide promotes cholesterol efflux and reduces atherosclerosis in mice.
about
Functionally defective high-density lipoprotein and paraoxonase: a couple for endothelial dysfunction in atherosclerosisHDL in sepsis - risk factor and therapeutic approachNovel concepts in HDL pharmacology.Novel Apo E-Derived ABCA1 Agonist Peptide (CS-6253) Promotes Reverse Cholesterol Transport and Induces Formation of preβ-1 HDL In VitroHDL as a prognostic biomarker for coronary atherosclerosis: the role of inflammation.Tomatoes, lysophosphatidic acid, and the small intestine: new pieces in the puzzle of apolipoprotein mimetic peptides?Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport.Structure and lipid interactions of an anti-inflammatory and anti-atherogenic 10-residue class G(*) apolipoprotein J peptide using solution NMR.5A, an apolipoprotein A-I mimetic peptide, attenuates the induction of house dust mite-induced asthmaApolipoprotein mimetic peptides: Mechanisms of action as anti-atherogenic agents.Apolipoprotein A-I and its mimetics for the treatment of atherosclerosis.An apolipoprotein A-I mimetic peptide designed with a reductionist approach stimulates reverse cholesterol transport and reduces atherosclerosis in mice.A novel apolipoprotein C-II mimetic peptide that activates lipoprotein lipase and decreases serum triglycerides in apolipoprotein E-knockout miceNew kids on the block: the emerging role of apolipoproteins in the pathogenesis and treatment of asthma.Regulation of ABCA1 functions by signaling pathwaysHelix stabilization of amphipathic peptides by hydrocarbon stapling increases cholesterol efflux by the ABCA1 transporter.Apolipoprotein mimetic peptides: a new approach for the treatment of asthma.The effect of phospholipid composition of reconstituted HDL on its cholesterol efflux and anti-inflammatory propertiesRegulation of reverse cholesterol transport - a comprehensive appraisal of available animal studies.Quercetin enhances ABCA1 expression and cholesterol efflux through a p38-dependent pathway in macrophagesHydrophobic amino acids in the hinge region of the 5A apolipoprotein mimetic peptide are essential for promoting cholesterol efflux by the ABCA1 transporter.Creation of Apolipoprotein C-II (ApoC-II) Mutant Mice and Correction of Their Hypertriglyceridemia with an ApoC-II Mimetic Peptide.Antagonism of scavenger receptor CD36 by 5A peptide prevents chronic kidney disease progression in mice independent of blood pressure regulation.Amphipathic polyproline peptides stimulate cholesterol efflux by the ABCA1 transporter.Modeling Smith-Lemli-Opitz syndrome with induced pluripotent stem cells reveals a causal role for Wnt/β-catenin defects in neuronal cholesterol synthesis phenotypesLecithin cholesterol acyltransferase: an anti- or pro-atherogenic factor?A Short Synthetic Peptide Mimetic of Apolipoprotein A1 Mediates Cholesterol and Globotriaosylceramide Efflux from Fabry Fibroblasts.Synthetic high-density lipoproteins for delivery of 10-hydroxycamptothecin.Pegylation of high-density lipoprotein decreases plasma clearance and enhances antiatherogenic activity.Relapsing-remitting multiple sclerosis patients display an altered lipoprotein profile with dysfunctional HDL.Recombinant high-density lipoprotein formulations.Homocysteine, Paraoxonase-1 and Vascular Endothelial Dysfunction: Omnibus viis Romam Pervenitur.High-density lipoprotein mimetics: promises and challenges.The Potential Therapeutic Application of Peptides and Peptidomimetics in Cardiovascular Disease.High-density Lipoprotein and Low-density Lipoprotein Therapeutic Approaches in Acute Coronary Syndromes.The 5A apolipoprotein A-I (apoA-I) mimetic peptide ameliorates experimental colitis by regulating monocyte infiltration.In vivo tissue cholesterol efflux is reduced in carriers of a mutation in APOA1.Apolipoprotein A-II: still second fiddle in high-density lipoprotein metabolism?Mimetic peptides of human apoA-I helix 10 get together to lower lipids and ameliorate atherosclerosis: is the action in the gut?Apolipoprotein A1 potentiates lipoxin A4 synthesis and recovery of allergen-induced disrupted tight junctions in the airway epithelium.
P2860
Q24603711-46E2CFFF-3EBC-408A-AE93-4B12ED1C3D3AQ26777964-45AFD232-2465-4D2B-8811-70E4F7A183DFQ27692691-A1F02CA0-17CC-4B88-8E9B-CAE93FC76D86Q28546760-3A234D07-203F-481C-8741-A5CB89A774ADQ30251918-59616E7B-455E-4EBF-ADCB-FA26E1CDBD13Q33356762-019B721B-E9C3-40A9-99BD-1143B17EEC54Q34155049-6B2BDD26-360D-4BEC-9E7A-3BC82203C000Q34384359-1D467B39-0A40-4248-8134-D2C5F87483A6Q34449116-C6A08908-4B09-421F-A1A3-D110FE9A9300Q34594140-CF267053-38B3-4825-957F-DE2DF600B3FDQ34781496-C365C106-4C6D-4C81-8ED0-79FDEAC0D3BAQ34851167-8C03F17C-4EED-4C21-8788-321AFE7F592FQ34946523-E7DBE569-57EE-4075-915F-7EC96D586898Q35267682-4EB8540D-D367-43F9-8082-A27AED6B4063Q35626943-D3CE6762-F512-4236-8411-B4591FF18DBEQ35660283-DD39484E-0F77-448D-8B8C-D1EB11EC3145Q35815986-E20F6E07-482F-4B6E-B4AB-57F2BF92B514Q35994365-2270B1D6-3803-4133-BBAF-66FD2F6AE478Q36007212-90EC00D0-5EB8-41E4-983A-95C22CB0B65EQ36145207-6EADC05A-CE93-40CA-B7CD-60AA13FF1E7FQ36497600-7F9F3F60-4256-4075-960F-742BAF401FBAQ36503047-0D771CF8-00A0-404B-9F73-642202BB62A9Q36707848-ECBBA51D-08DA-48B5-848C-3FB78A8182DCQ36761029-B85374BD-115B-4CB7-B888-7CDA820BBF34Q36772356-6350CBFE-E481-4CB6-A83E-C917BB5532D0Q37224981-E961A19D-2A73-4386-BC35-EBFEE0F24F07Q37329233-CB662E6A-27D7-4DE3-874F-6D9C7A7A516AQ37446423-F06152DD-6979-485A-AFBB-F99EC2257876Q37528535-EBDE8435-D80D-44C2-96F9-267CC528F731Q37661249-A1187571-398E-4AC7-AC4E-CB39CBD1B38BQ37807911-14754701-CF70-4C9D-8470-B806AE858A1EQ38266911-54E14904-C943-4EFB-AD50-D3EBEACD89B3Q38650575-673B699D-AD73-4F71-81A3-DA9EDA63A780Q38767234-DC61A7A2-1BC8-4076-8EC9-9E5943606EC0Q38965138-EB89F6A5-E07D-4FB5-82DC-B3298F019013Q41341405-7275E961-9303-442A-BEAA-A9E7AD7595C7Q42150261-C095B8AD-2418-4189-8D9B-E03371302C44Q42791504-687030BE-651F-4E33-87A0-FF9119E2933CQ42913663-75C8B1E1-694D-4A21-832D-6600186C510EQ47929030-D3997E7A-60D1-4977-8C22-BD41679F7D84
P2860
5A apolipoprotein mimetic peptide promotes cholesterol efflux and reduces atherosclerosis in mice.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
5A apolipoprotein mimetic pept ...... duces atherosclerosis in mice.
@ast
5A apolipoprotein mimetic pept ...... duces atherosclerosis in mice.
@en
5A apolipoprotein mimetic pept ...... duces atherosclerosis in mice.
@nl
type
label
5A apolipoprotein mimetic pept ...... duces atherosclerosis in mice.
@ast
5A apolipoprotein mimetic pept ...... duces atherosclerosis in mice.
@en
5A apolipoprotein mimetic pept ...... duces atherosclerosis in mice.
@nl
prefLabel
5A apolipoprotein mimetic pept ...... duces atherosclerosis in mice.
@ast
5A apolipoprotein mimetic pept ...... duces atherosclerosis in mice.
@en
5A apolipoprotein mimetic pept ...... duces atherosclerosis in mice.
@nl
P2093
P2860
P356
P1476
5A apolipoprotein mimetic pept ...... duces atherosclerosis in mice.
@en
P2093
Alan T Remaley
Denis Sviridov
Dmitri Sviridov
Jason Voogt
Jayraz Luchoomun
John Stonik
Marc Hellerstein
Marcelo J A Amar
Scott Turner
Stephen Demosky
P2860
P304
P356
10.1124/JPET.110.167890
P407
P577
2010-05-19T00:00:00Z